SEC Filings

Date Filing Type Filing Description Download / View
Feb 21, 2017 8-K Current report filing
Feb 17, 2017 SC 13G Statement of Ownership
Feb 17, 2017 SC 13G Statement of Ownership
Feb 15, 2017 SC 13G Statement of Ownership
Feb 10, 2017 4 Statement of Changes in Beneficial Ownership
Feb 10, 2017 3 Initial Statement of Beneficial Ownership
Feb 10, 2017 8-K Current report filing
Feb 10, 2017 SC 13G/A Amended Statement of Ownership
Feb 09, 2017 424B5 Prospectus filed pursuant to Rule 424(b)(5)
Feb 07, 2017 4 Statement of Changes in Beneficial Ownership
Feb 07, 2017 424B2 Prospectus filed pursuant to Rule 424(b)(2)
Feb 07, 2017 8-K Current report filing
Jan 31, 2017 8-K Current report filing
Jan 30, 2017 SC 13G Statement of Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 24, 2017 4 Statement of Changes in Beneficial Ownership
Jan 19, 2017 4 Statement of Changes in Beneficial Ownership
Jan 19, 2017 4 Statement of Changes in Beneficial Ownership
Jan 19, 2017 4 Statement of Changes in Beneficial Ownership
Jan 11, 2017 SC 13G/A Amended Statement of Ownership
Jan 09, 2017 8-K Current report filing

Email Alerts

Email Address *
Mailing Lists *





Investor Contact

Remy Bernarda, IRC

SVP, Investor Relations & Corporate Communications

ir@galenabiopharma.com